Bioavailability Enhancement Solutions
At Almac, we understand poor solubility remains one of the most persistent challenges in drug development. It is fundamental to understand the characteristics of an API to maximize a formulation’s solubility, stability and therapeutic impact.
Our bioavailability enhancement solutions are designed to overcome these challenges through proven technologies and extensive analytical data.
A Seamless Path to Clinical Success
At Almac, we bridge the gap between drug substance and drug product. From pre-formulation all the way to GMP manufacture, trust Almac to transform your drug product’s potential into a clinical-ready solution.
Single Partner Approach
Providing a fully integrated approach from a single source ensures that the formulation and processing knowledge gained throughout the development phase is effectively transferred for a seamless experience.
This end-to-end, integrated process means access to our proven technology, facilities and expert formulation development teams.
Meet our experts
Jonathan Loughrey
Director of Chemical Development, Almac Sciences
Connect on LinkedIn
Terry Ernest
Director of Manufacturing Science and Technology, Almac Pharma Services
Connect on LinkedIn
James Hurst
VP of Operations & Charnwood Site Head, Almac Pharma Services
Connect on LinkedIn
Sander van den Ban
Director of Operations, Manufacturing, Almac Pharma Services
Connect on LinkedIn
Manas Tilekar
Associate Director of Formulation Development, Almac Pharma Services
Connect on LinkedIn
Conor Long
Associate Director of Manufacturing Science & Technology, Almac Pharma Services
Connect on LinkedIn